Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells

While targeted therapy brought a new era in the treatment of BRAF mutant melanoma, therapeutic options for non-BRAF mutant cases are still limited. In order to explore the antitumor activity of prenylation inhibition we investigated the response to zoledronic acid treatment in thirteen human melanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Garay, Tamás, Kenessey, István, Molnár, Eszter, Juhász, Éva, Réti, Andrea, László, Viktória, Rózsás, Anita, Dobos, Judit, Döme, Balázs, Berger, Walter, Klepetko, Walter, Tóvári, József, Tímár, József, Hegedűs, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315579/
https://www.ncbi.nlm.nih.gov/pubmed/25646931
http://dx.doi.org/10.1371/journal.pone.0117021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315579/
https://www.ncbi.nlm.nih.gov/pubmed/25646931
http://dx.doi.org/10.1371/journal.pone.0117021

Ejemplares similares